1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Canine Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okano, S; Tagawa, M; Urakawa, N | 1 |
| Ashida, Y; Kitao, S; Kobayashi, K; Kyotani, K; Mochizuki, T; Nishizono, K; Scott, MA; Tsuchiya, R; Yamada, T | 1 |
| Candler, RV; Carroll, RC; Jones, JB; Lothrop, CD; Pratt, HL; Urso, IM | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Canine Diseases
| Article | Year |
|---|---|
Effect of platelet activating factor antagonist (CV-3988) on 6-keto-PGF1 alpha and thromboxane B2 in dogs with experimental endotoxin-induced shock.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dog Diseases; Dogs; Hemodynamics; Phospholipid Ethers; Platelet Activating Factor; Shock, Septic; Thromboxane B2 | 1995 |
Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
Topics: Animals; Blood Coagulation Tests; Dog Diseases; Dogs; Endotoxemia; Female; Isoquinolines; Leukocyte Count; Lipopolysaccharides; Male; Neutropenia; Pilot Projects; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Count; Pyridinium Compounds; Radioimmunoassay; Tetrahydroisoquinolines; Thrombocytopenia | 1999 |
Characterization of platelet function in cyclic hematopoietic dogs.
Topics: Animals; Blood Proteins; Dog Diseases; Dogs; Female; Hematopoiesis; Heterozygote; Male; Neutropenia; Periodicity; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Storage Pool Deficiency; Thrombin; Type C Phospholipases | 1991 |